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ARCH Abstract/Summary 
 Mitochondria are complex and dynamic organelles, primarily responsible for the 
energy production of the cell. However, mitochondria are also imperative for stress 
responses, cell growth, and cell survival and death. In cancer, the mitochondrial functions 
of bioenergetics, i.e. metabolism, and apoptosis mechanisms are affected. In the 
Chambers lab, I am responsible for understanding the sudden dependency of cancer cells 
on glutamine metabolism. This will be made possible by experimenting for a better 
understanding of the metabolic pathways for glutamine and Sab/JNK phosphorylation 
signaling. Sab-mediated signaling is a newly researched contributor to apoptosis 
signaling in mitochondria. The experiments to be conducted will make use of uterine 
cancer cell lines, AN3CA and SKUT-1. The experiments measuring the cancer cell 
metabolism under the influence of various drugs will be conducted using the Seahorse 
XF-96 extracellular flux analyzer. I will also evaluate the levels of various proteins 
involved in glutaminolysis and the proteins involved in Sab-mediated signaling. The 
protein levels will be analyzed using western blots, in order to quantify their expression. 
We hypothesize that the AN3CA and SKUT-1 cell lines would show distinct proteins in 
each of their metabolic pathways, explaining the difference in chemotherapy sensitivity, 
based on evidence from Seahorse analysis and Western Blot data. This project is 
significant, as it will provide a new molecular mechanism for regulating metabolism in 
uterine cancer cells. This will be the first such study in the field of uterine cancer and 
paves the way for new therapeutic options.  
